Carmolex, Inc., USA, is Pleased to Announce it has Entered into an…

Carmolex's advanced solutions/platform is poised to deliver Sanofi in Germany with a diverse set of high-quality chemotypes, pre-clinical, low molecular weight hits against biologically relevant...

(PRWeb October 18, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: